FindTrial
Sign In

long-term outcome after Ahmed glaucoma implant surgery in Koreans

long-term outcome after Ahmed glaucoma implant surgery in Koreans

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0005136
Enrollment
150
Registered
2020-06-17
Start date
2020-07-01
Completion date
Unknown
Last updated
2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Seoul Metropolitan Government Seoul National University Boramae Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients over 20 years of age and who undergo Ahmed glaucoma drainage device implant to lower intraocular pressure for the first time

Exclusion criteria

Exclusion criteria: (1) Eyes with the number of central corneal endothelial cells less than 1500 or impossible to measure (2) Eyes with previous Ahmed glaucoma drainage device implant surgery (3) congenital glaucoma (4) preexisting corneal pathology (5) previous corneal grafts (6) iridocorneal endothelial syndrome (7) vitreous in the anterior chamber (8) primary angle closure glaucoma (9) Cataract, glaucoma, or retinal surgery within 6 months of enrollment

Design outcomes

Primary

MeasureTime frame
Corneal endothelial cell changes compared to baseline—

Secondary

MeasureTime frame
Changes in intraocular pressure compared to baseline—

Countries

Korea, Republic of

Contacts

Public ContactSeok Hwan Kim

Seoul Metropolitan Government Seoul National University Boramae Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026